RESTORATION OF DOPAMINE FUNCTION IN PARKINSON'S DISEASE
RESTORATION OF DOPAMINE FUNCTION IN PARKINSON'S DISEASE
批准号:
6618023
负责人:
Greg A. Gerhardt
金额:
$109.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-30 至 2005-08-09
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The neuroestorative and neuroprotective tropic actions of GDNF on midbrain dopamine (DA) neurons provide a promising therapeutic approach for the treatment of Parkinson's disease. As with many tropic factors, optimum success of this tropic factor depends on focal and controlled delivery of the protein to affect the function of DA neurons, without producing unwanted side effects. It is our central hypothesis that chronic intracerebroventricular or intraputamenal GDNF willproduce effects on damaged DA neurons with greater efficacy, potency and reduced side effects as compared to other methods of delivery. 1. We propose to use a novel indwelling pump that can deliver GDNF chronically in the freely-moving MPTP-lesioned monkey to evaluate two sites of delivery: the lateral ventricle and the putamen. 2. We will also investigate washout of GDNF and re-instatement of the trophic factor in both infusion paradigms. The different highly integrated Projects and Cores will provide key data regarding the functional effects of chronic GDNF treatments to DA neurons, and form the foundation for a Parkinson's Disease Center of Excellence. Project 1 will use microdialysis, in vivo electrochemistry and postmortem HPLC-EC methods to study the nigrostriatal pathway of unilateral MPTP-lesioned monkeys that have received chronic infusions of GDNF. Project 2 will investigate the behavioral consequences of the GDNF infusions and study potential functional changes to DA neurons using fMRI methods. Project 3 will carryout tract tracing and immunohistochemical measures of DA neurons in the same groups of chronically treated monkeys. The Cores A-D will all provide needed support for the experiments outline in Projects 1-3. These studies will answer key questions regarding the chronic delivery of a trophic factor in freely-moving and behaving rhesus monkeys. Such data could lay the foundation for the use of trophic molecules for the treatment of Parkinson's disease in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tonic and Phasic Glutamate Release from Psychomotor Stimulants
-
批准号:8446339
-
项目类别:
-
资助金额:$17.82万
-
财政年份:2012
-
负责人:Greg A. Gerhardt
-
依托单位:
Tonic and Phasic Glutamate Release from Psychomotor Stimulants
-
批准号:8322257
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2012
-
负责人:Greg A. Gerhardt
-
依托单位:
NEUROCHEMICAL STUDIES OF THE AGING BASAL GANGLIA
-
批准号:7371007
-
项目类别:
-
资助金额:$17.26万
-
财政年份:2007
-
负责人:Greg A. Gerhardt
-
依托单位:
Neuropharmacological Studies
-
批准号:7009769
-
项目类别:
-
资助金额:$24.37万
-
财政年份:2005
-
负责人:Greg A. Gerhardt
-
依托单位:
Administrative Core
-
批准号:7009774
-
项目类别:
-
资助金额:$9.26万
-
财政年份:2005
-
负责人:Greg A. Gerhardt
-
依托单位:
Neurochem Chip: Methodology to Study Untethered Rats
-
批准号:7252437
-
项目类别:
-
资助金额:$41.17万
-
财政年份:2003
-
负责人:Greg A. Gerhardt
-
依托单位:
Neurochem Chip: Methodology to Study Untethered Rats
-
批准号:6704868
-
项目类别:
-
资助金额:$41.13万
-
财政年份:2003
-
负责人:Greg A. Gerhardt
-
依托单位:
Neurochem Chip: Methodology to Study Untethered Rats
-
批准号:6807017
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2003
-
负责人:Greg A. Gerhardt
-
依托单位:
Neurochem Chip: Methodology to Study Untethered Rats
-
批准号:7084604
-
项目类别:
-
资助金额:$41.16万
-
财政年份:2003
-
负责人:Greg A. Gerhardt
-
依托单位:
Neurochem Chip: Methodology to Study Untethered Rats
-
批准号:6920043
-
项目类别:
-
资助金额:$40.93万
-
财政年份:2003
-
负责人:Greg A. Gerhardt
-
依托单位:
Neurochem Chip: Study of Neurotransmitter Release
-
批准号:6523652
-
项目类别:
-
资助金额:$14.26万
-
财政年份:2001
-
负责人:Greg A. Gerhardt
-
依托单位:
Neurochem Chip: Study of Neurotransmitter Release
-
批准号:6447726
-
项目类别:
-
资助金额:$14.48万
-
财政年份:2001
-
负责人:Greg A. Gerhardt
-
依托单位:
Quantitative neurochemical studies of effects of chronic delivery of GDNF
-
批准号:6353142
-
项目类别:
-
资助金额:$16.9万
-
财政年份:2000
-
负责人:Greg A. Gerhardt
-
依托单位:
AGE RELATED DECLINES IN MOVEMENT FUNCTIONS IN RHESUS MONKEYS
-
批准号:6299362
-
项目类别:
-
资助金额:$18.57万
-
财政年份:2000
-
负责人:Greg A. Gerhardt
-
依托单位:
Core--Teaching and training
-
批准号:6353147
-
项目类别:
-
资助金额:$16.9万
-
财政年份:2000
-
负责人:Greg A. Gerhardt
-
依托单位:
Core--Teaching and training
-
批准号:6233745
-
项目类别:
-
资助金额:$16.9万
-
财政年份:1999
-
负责人:Greg A. Gerhardt
-
依托单位:
RESTORATION OF DOPAMINE FUNCTION IN PARKINSON'S DISEASE
-
批准号:6529530
-
项目类别:
-
资助金额:$107.08万
-
财政年份:1999
-
负责人:Greg A. Gerhardt
-
依托单位:
Restoration of Dopaminergic Function in Parkinson's Disease
-
批准号:6961633
-
项目类别:
-
资助金额:$115.09万
-
财政年份:1999
-
负责人:Greg A. Gerhardt
-
依托单位:
RESTORATION OF DOPAMINE FUNCTION IN PARKINSON'S DISEASE
-
批准号:6394328
-
项目类别:
-
资助金额:$104.28万
-
财政年份:1999
-
负责人:Greg A. Gerhardt
-
依托单位:
Quantitative neurochemical studies of effects of chronic delivery of GDNF
-
批准号:6233740
-
项目类别:
-
资助金额:$16.9万
-
财政年份:1999
-
负责人:Greg A. Gerhardt
-
依托单位:
国内基金
海外基金
登录
查看更多内容
DRD2/ERK/β-catenin信号联合Dopamine/ERK/TH调节环介导慢性应激促进脑胶质瘤恶性进展的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:周秀萍
-
依托单位:
11C-N-CH3-Dopamine PET/MRI心脏神经显像对射血分数保留的心衰的实验研究
-
批准号:82171969
-
项目类别:面上项目
-
资助金额:56万元
-
批准年份:2021
-
负责人:王雪梅
-
依托单位:
11C-N-CH3-Dopamine心肌Micro PET/CT显像对糖尿病心脏自主神经病变的评估
-
批准号:82060323
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2020
-
负责人:何玉林
-
依托单位:
11C-N-CH3-Dopamine神经显像对心肌"缺血记忆"的实验研究
-
批准号:81460271
-
项目类别:地区科学基金项目
-
资助金额:46.0万元
-
批准年份:2014
-
负责人:王雪梅
-
依托单位:
11C-dopamine PET/CT显像对急性心肌缺血状况下交感神经功能变化的实验研究
-
批准号:81060019
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:王雪梅
-
依托单位: